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Abstract The functional domain for candidacidal activity of 
bactenecin 5 has been determined by synthesizing bactenecin 5 
and its fragments [1-22 (BN22), 7-22 (BN16) and 20-43 (BC24)]. 
The N-terminal sequence BN16 retained the candidacidal po- 
tency of the parent molecule and this region appears to be the 
candidacidal domain. The circular dichroism spectra of these 
peptides indicate the presence of largely poly-L-proline II confor- 
mations in aqueous solutions and in lipid vesicles. The coupling 
constant (JNH.Ct~H) values, and a set of medium- and short-range 
nuclear Overhauser effects observed for the N-terminal peptide 
(BN16) in the two-dimensional nuclear magnetic resonance sug- 
gest that poly-L-proline II helix could be the biologically active 
conformation. 
Key words': Antimicrobial peptide; Candidacidal activity; 
Peptide conformation; Circular dichroism; 2D NMR 
1. Introduction 
Bactenecins belong to the family of proline- and arginine-rich 
antibiotics found in the granules of bovine neutrophils [1,2]. 
Two polypeptides designated as bactenecin 5 (Bac 5) and bacte- 
necin 7 (Bac 7) have been purified and examined for anti- 
bacterial activity [1,3]. They have been reported to be synthe- 
sized in immature myeloid cells of the bone marrow and stored 
as inactive probactenecins in the large granules [4]. Neutrophil 
stimulation with microbes has been shown to trigger the re- 
moval of the proportion and activation of these peptides [5]. 
The primary structure determination using plasma desorption- 
mass spectrometry has shown Bac 5 and Bac 7 sequences to 
contain 42 and 59 residues, respectively [3]. However, it has 
recently been established from cloning and sequence analyses 
that Bac 5 is a 43-residue polypeptide [6]. The mechanism of 
cidal action of bactenecins has been reported to involve their 
interaction with the outer membrane of susceptible micro- 
organisms followed by a rapid translocation to the inner mem- 
brane and impairment of energy-dependent membrane activi- 
ties [2,3,7]. Despite the importance of bactenecins in the non- 
immune host defense systems, there are relatively few reports 
on the secondary structure and structure-function a alyses of 
these pharmacologically active polypeptides. Though the mech- 
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anism of cidal action of bactenecins has been suggested to in- 
volve membrane interaction [7], the conformations they 
acquire in lipid environment have not yet been reported. Bacte- 
necins have been shown to be active against a broad range of 
bacteria and enveloped viruses [3]. However, their effects on 
fungal organisms have not been reported. In this paper, we 
report the functional domain and the conformational require- 
ments for candidacidal ctivity of Bac 5. We also describe the 
2D-NMR of the active region 7-22 of Bac 5. 
2. Materials and methods 
2.1. General materials and methods 
Amino acid derivatives, DPPC, phenylacetamidomethyl and 4-meth- 
ylbenzhydrylamine resins were purchased from Sigma (St. Louis, MO) 
and Bachem (Torrance, CA). All peptides were synthesized using a 
Beckman System 990 synthesizer. HPLC was carried out on a Gilson 
Rabbit-HP system interfaced to an Apple IIe microcomputer using a 
Rainin Dynamax-60A reversed-phase C 18 column (10 × 250 mm) cou- 
pled to a guard column (10 × 50 mm) employing acetonitrile-water 
(each containing 0.1% trifluoroacetic a id) linear gradient elution (flow 
rate 1.5 2.0 ml min -1) mode with detection at 230 nm. Amino acid 
analysis was performed on a Beckman System 6300 amino acid analy- 
ser. The amino acid sequences of peptides were verified by sequence 
analysis using an Applied Biosystems Model 471A Protein Sequencer 
interfaced with a Hewlett Packard HP3394A integrator. 
2.2. Peptide synthesis' and purification 
Bactenecin 5 and its fragments shown in Fig. 1 were synthesized by 
standard solid-phase procedures using 4-methylbenzhydrylamine and 
phenylacetamidomethyl resins (for Bac 5 and its fragments, respec- 
tively) and N-tert-butyloxycarbonyl (t-Boc) amino acids as described 
in our previous publications [8,9]. The side-chain protecting roups 
were the following: N-tosyl (Arg) and O-2-bromobenzyloxycarbonyl 
(Tyr). Peptides were purified by reversed-phase HPLC and fully charac- 
terized by sequence and amino acid analyses and examined in cationic 
[10] and SDS [11] PAGE systems which showed a single band. The 
HPLC retention time, amino acid composition and migration in the 
cationic and SDS PAGE systems of synthetic Bac 5 were found to be 
in good agreement with those of the native molecule isolated from 
bovine neutrophils using the previously reported procedures [1,12]. 
2.3. Measurement of candidacidal ctivity 
Candida albicans train obtained from a clinical isolate from a den- 
ture-induced stomatitis (DIS) patient was used. The identity of the 
clinical isolate was verified by the Yeast System (Flow Laboratories, 
McLean, VA). Organisms were streaked onto Sabouraud Dextrose 
Agar plates (Difco Laboratories, Detroit, MI) and maintained at4 ° C. 
One colony of C albicans from this plate was inoculated into 10 ml of 
yeast synthetic growth media containing sucrose, salts and biotin and 
incubated for 48 h at 25°C in a shaker otating at 200 rpm. After this 
period, the population of yeast cells was in the late logarithmic phase 
growth. The cell morphology was determined and found to be uni- 
formly blastospores by phase-contrast microscopy. The antifungal c- 
tivity of Bac 5 and its fragments were assessed in vitro against 
C albicans. The assay was performed as described previously for sali- 
vary histatin 5and its fragments [8]. We refer to the candidacidal ction 
of peptides as a loss of viability of cells, since the inability of the yeast 
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to replicate following removal of peptides is considered non-viable. 
Thus, the assay used in this study measured only fungicidal ctivity. The 
candidacidal ctivity of Bac 5 and its fragments has been found to be 
influenced by peptide concentration a d incubation time. The time- 
dependent loss of viability of cells induced by Bac 5 and its fragments 
at different concentrations have shown that maximal loss in cell viabil- 
ity could be reached within 50 min after incubation for all peptides. 
2.4. CD 
CD spectra were recorded at 30°C with a JASCO J-600 spectropo- 
larimeter interfaced to an IBM PS/2 microcomputer. Measurements 
were carried out in cells with 0.1 cm path length using a peptide concen- 
tration of 0.03~0.05 raM. The peptide in aqueous DPPC dispersion was 
prepared as described previously [13]. The lipid peptide molar atio was 
20 : 1. CD band intensities are expressed as molar ellipticities, [O]M in 
deg. cm 2. dmoF ~. 
2.5. NMR measurements 
The purified BN16 (7 mg) was dissolved in 630 pl of double distilled 
water and 70/tl of 2H20 (Cambridge Isotope Laboratories, Woburn, 
MA). All 1D- and 2D-NMR experiments used for conformational 
analyses were performed at 30°C using a Varian 500 MHz VXR-500 
spectrometer quipped with a SUN Sparcstation 2 as described previ- 
ously [14)]. The TOCSY [15,16] experiments were recorded using a 
MLEV-16 pulse sequence for the spin lock with a field strength of ~ 5.6 
kHz and a trim pulse of 2 ms using an isotropic mixing period of 65 
ms. The 2D-NOE experiments [17-18] were performed with a mixing 
time of 150 ms after ascertaining that spin diffusion is not significant 
at this mixing time. The coupling constant (JNa_caH) values were deter- 
mined from the 1D spectrum with a high digital resolution of 0.1 Hz. 
Hydrogen~leuterium (~H-~ZH) exchange of the amide groups and vari- 
able temperature experiments have been performed as described previ- 
ously [14]. Computer modeling of the molecular conformation f BN16 
was carried out using SYBYL molecular modeling software version 5.5 
(Tripos Associates, St. Louis, MO) on an Evans & Sutherland Worksta- 
tion 3-32 as described in our previous publication [14]. 
3. Results  and discussion 
3.1. Candidacidal activity 
The candidacidal activity of Bac 5 and its fragments for the 
DIS strain are summarized in Fig. 2. The EIs0 (molar concen- 
tration of peptide which would induce half-maximal loss in cell 
viability) value of synthetic Bac 5 is in good agreement with that 
of the native molecule. The candidacidal potency of the N- 
terminal fragments, BN22 and BN16, are comparable to that 
of Bac 5 whereas the C-terminal sequence (BC24) appears to 
be significantly less active (Fig. 2). The fragment BC24 has 
diminished positive charge at the N-terminus as compared with 
Bac 5, BN16 and BN22. Hence, the lowered activity observed 
for BC24 indicates that the positive charge at the N-terminus 
is crucial for high candidacidal activity. The EIs0 values of 
BN16 and BN22 suggest that the first six residues (R-F-R-P-P- 
I) at the N-terminal of BN22 (Fig. 1) may not be essential for 
candidacidal activity. Bac 5 has an amide function at the C- 
terminal whereas the fi'agments have a carboxyl function. The 
fact that the N-terminal fragments retain the activity of the 
whole molecule suggests that the amide function at the C- 
terminal of Bac 5 may not be essential for fungicidal activity. 
Collectively, the data suggest hat the region 7-22 of Bac 5 
could be the functional domain for fungicidal activity. A hydro- 
phobic sequence at the C-terminus and a positively charged 
N-terminus as in the sequence of 7-22 (BN16) of Bac 5 appear 
critical to elicit appreciable candidacidal ctivity. 
3.2. CD studies 
The CD spectra of Bac 5 in sodium phosphate buffer shown 
in Fig. 3 has a strong broad negative g-~* band at ~202 nm 
([O]M = -67.82 x 104 deg-cm 2' dmo1-1) with the n-:r* band ap- 
proaching towards the positive minimum in aqueous olution. 
The CD spectrum of synthetic Bac 5 in aqueous buffer is in 
good agreement with that of the native sequence suggesting the 
optical purity of the synthesized peptide. A strong negative 
band a t -206  nm with a weak positive band at ~229 nm is char- 
acteristic of poly-L-proline II helical structure [19]. The absence 
of the weak positive band expected for poly-L-proline II helix 
and the shift in the strong negative ~-:r* band from ~206 to 202 
nm is attributable tothe presence of only one half of the tertiary 
amide groups [20] or to a slight deviation from the ideal poly- 
L-proline II (q~ = -78 °, ~ = 149 ° and co -- 180 °) helical confor- 
mation. The presence of minor populations of cis conforma- 
tions (poly-L-proline I, co = 0 °) may also cause a change in the 
positive n-zr* transition and a shift in the ~-~* transition to- 
wards shorter wavelength. The CD spectrum of synthetic Bac 5 
in aqueous buffer is in good agreement with that of the native 
sequence. The CD spectra of the fragments of Bac 5 also resem- 
ble the CD spectra of Bac 5 with lowered ellipticity values 
(figure not shown) which could be attributed to their shorter 
Bac7: 
5 10 15 20 25 30 35 40 
R-R- I -R-P-R-P-P-R-L-P-R-P-R-P-R-P-L-P-F-P-R-P-G•P-R-P- I -P -R-p-L-P-F-P-R-P-G-P-R-P- I -  
45 50 55 59 
P-R-P-L-P-F-P-R.P-G-P-R-P- I -P -R.P  
5 10 15 20 25 30 35 40 43 
Bac 5: R•F-R-P-P-•-R-R-•-P-•-R•P-•-F-Y-P•P-F•R-P-p-•-R-P-P-•-F-P-P-•-R-P-P-F-R-P-P-L-G•P-F•P 
BN22 : R -F -R-P -P . I -R -R-P -P - I -R -P -p -F -y -p -P .F -R-P . !  ~ 
BNI6 : R-R-P-P- I -R-P-P-F-Y-  P -P -F .R -P -P  
BC24 : R -P -P - I -R -P -P - I -F -P -P -1 -R-P -P -F -R-P -P -L -G-P -F -P  
Fig. 1. Amino acid sequences of Bac 7, Bac 5 and its fragments. Synthetic Bac 5 has the amide function at the C-terminal whereas the fragments 
have the carboxyl function. The one letter symbol used for amino acids in the sequences are described as in IUPAC-IUB Commission on Biochemical 
Nomenclature [31]. 
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Fig. 2. Dependence of % loss of viability of C. albicans (DIS) on peptide 
concentration. (a)synthetic Bac 5, (b) native Bac 5, (c) BC24, (d) BN22 
and (e) BN16. The EIs~ = molar concentration f peptide required to 
induce half-maximal loss in cell viability as determined from the con- 
centration-effect curve. 
chain length [8,9]. In DPPC vesicles (Fig. 3), the intensity of the 
~-~* transition increases with a shift in the band position to- 
wards longer wavelength as compared with that in phosphate 
buffer suggesting that peptide molecules may associate in lipid 
bilayer to form a higher order polyproline helical structure. The 
CD data of bactenecin peptides reflect he existence of a major 
population of poly-L-proline II conformations in aqueous olu- 
tion and in lipid vesicles. 
3.3. NMR studies 
The high biological activity of BN 16 provides a strong stim- 
ulus to determine its conformation i  aqueous solution using 
2D-NMR. This peptide is unique with two non-proline residues 
flanked by two adjacent prolines in the sequence (Fig. 1). More- 
over, both the in vivo and in vitro activity of Bac 5 could reflect 
the candidacidal potency of the active fragments, as the parent 
molecule is highly susceptible to proteolytic degradation. The 
observed ~H NMR resonances are due to a major population 
(95%) of exclusively trans prolines with additional resonances 
(5%) that correspond to cis prolines. Conformational nalysis 
has been carried out only for the major all trans peptide mole- 
cules. The 2D-TOCSY and NOESY spectra allowed un- 
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Fig. 3. The CD spectra of synthetic (a) and native (b) Bac 5 recorded 
at 30°C in sodium phosphate buffer at pH 7.4 and the CD spectrum 
of synthetic Bac 5 (c) in DPPC vesicles (peptide :lipid molar atio 1:20). 
ambiguous assignment of resonances to individual amino acids 
as shown for the backbone amide resonance connectivities to
the respective side-chain protons (Fig. 4). The c~N (i, i+ l )  and 
c~6 (i, i+ l )  NOE connectivities have b en used to identify the 
non-proline and proline residues, respectively, in the sequence. 
The JNH.dZH values for the non-proline residues (6.9 7.8 Hz) 
provided in Fig. 5 suggest 0 values o f~-81-89  ° or ~-151-159 ° 
[21] for non-proline residues. However, the stereochemical con- 
straints imposed on the non-proline residues flanked by Pro 
residues indicate only the lower 0 values of -81-89 ° as the 
compatible conformational ngles [22-241 which are close to 
the poly-t~-proline II conformation (¢ = -78 °, ~t = 149 ° and 
co = 180°). 
The medium-range c~N (i, i) NOEs observed for most of the 
non-proline residues (Fig. 5) suggest a spatial distance of 3.0- 
3.2~_ between the respective protons and appear to be con- 
sistent with large gt (~ 140-150 °) values for these residues. The 
strong czN (i, i+l) ,  fiN (i, i), cz5 (i, i+ l )  NOE connectivities 
generate a distance of 2.2-2.4/~ between the respective protons. 
The weak cz~ (i, i+ l )  NOEs (Fig. 5) are consistent with a 
distance of 4.2M.6A. The 2D-NOE spectrum does not show 
any observable NN (i, i+ l )  NOEs for non-proline residues 
indicating spatial distances >4.8/k between the protons [25]. 
These interproton distances deduced from the NOE data are 
fully consistent with a poly-L-proline II conformation. In addi- 
tion, the absence of intramolecularly hydrogen bonded NH 
groups as shown by the high temperature coefficients (>0.0042 
ppm K -1) of NH resonances and the fast IH 2H exchange on 
amide groups (Fig. 5) are also in agreement with this semi- 
extended conformation• Collectively, the NMR and NOE data 
provide evidence that BN16 predominantly exists as poly-L- 
proline II conformers in aqueous olutions• The stereochemical 
preference of proline, the repetitive occurrence of adjacent Pro 
residues in the sequence and the high Chou-Fasman propensity 
of Arg residues for poly-L-proline structure lend further sup- 
port to the interpretations. 
3.4. Conformation and biological activity 
A family of 16 closely related structures generated for BN16 
using molecular modeling techniques and the NMR constraints 
7.2 LZ-- ¢-----~SZ~2ZT._-_-_-_-_-_-2_'Z_-Z----_-------Z -- -----Z--2Z-~,--2A--rgI4~.[----[[ZZ---[g --2-2--22:2---2222222Z--2"-'Z 
7.4 
7.6 
7.S 
[ ~---~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  ~- -~* - , - I 'Ue  9 & Tyrlo . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
_~_ ....................... ~ ....................... ~ ....... _............... 
8.0 o 
: : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : :  : : : : : : : : : : : : : : : : : : : : :  . . . . . . .  
s.2[ . . . . . . . .  -~  • 5 l J :  . . . . . . .  
) -0-  " o ................................................................. .era: ........ - ................ 
8.s.61 
8.s -d ............................ ~ ............................ ~-~----A~ 2 ..................... 
4.5 4.0 3.5 S.0 2.5 2.0 ~.5 i~0- -  - - -0 .~ 
rl (vvm) 
Fig. 4. Part of the TOCSY spectrum of BN16 showing the backbone 
amide and Arg side-chain amino resonance connectivities to C~H, C/~H, 
CrH and Call resonances• The spectrum was recorded in H20/=H20 at 
pH 3.8 and 30 °C. 
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are consistent with polyproline II helices. The average structure 
provided in Fig. 6 has 0 values (~-75 °) for all Pro residues very 
close to the allowed upper limit. The average backbone confor- 
mational angles of the structure are ~ = -85.2 °, 9' = 148.5 ° and 
co = 179.7 °, It is a single-stranded, extended helix with the 
backbone C = O and N-H groups projecting outward. The 
N-terminal of the BN16 helix is polar and charged ue to the 
presence of Argl, Arg 2 and Arg6, whereas the C-terminal con- 
sists of mostly hydrophobic residues uch as Pro, Phe, Ile and 
Tyr. The interaction of the bactenecin peptides with the micro- 
bial membranes appears to involve the electrostatic forces be- 
tween the positively charged residues and the negatively 
charged head groups of the membrane bilayer. Our results 
indicate that the positively charged Arg residues at the N- 
terminus eem to be important for candidacidal ctivity. Even 
the replacement of one Arg residue at the N-terminal dimin- 
ishes the candidacidal ctivity dramatically as observed for the 
C-terminal fragment BC24. The Influence of positively charged 
residues at the N-terminus on the orientation of the hydropho- 
bic domains in membrane proteins ha recently been reported 
[26]. Most antimicrobial cationic polypeptides have been re- 
ported to form amphiphilic ~-helical or fl-sheet structures [27- 
30]. The spontaneous insertion of these amphiphilic peptides 
into cell membranes have been suggested as the probable mech- 
anism of their candidacidal action [27,29]. The high candida- 
cidal potency observed for Bac 5 and the N-terminal BN16 
fragment emphasizes the importance of poly-L-proline II helical 
structure for microbial interaction and antifungal activity. 
In conclusion, our results demonstrate for the first time that 
bactenecin peptides are powerful candidacidal agents which 
prefer to adopt poly-L-proline II conformation i aqueous olu- 
tion and in lipid vesicles. The N-terminal 7 22 sequence of Bac 5 
appears to be the functional domain for candidacidal ctivity. 
Alternate occurrence of two adjacent Pro residues flanking two 
non-proline residues (basic residues, such as Arg, at the N- 
terminus and mostly hydrophobic residues at the C-terminus) 
and a chain length of 16 residues eem to be the structural 
requirements for eliciting appreciable candidacidal activity. 
The positive charge at the N-terminus appears to be essential 
for high candidacidal potency. The tendency of bactenecin pep- 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
RRP P I RP  PF  Y PPFRPP  
aN (i, i+1) 
(~5 (i, i+1) 
aN (i, i) 
[3N (i, i) . . . . .  
aa (i, i+l) 
JNH.CaH (Hz) 6.9 7.2 7.1 6.9 6.9 7.2 7.8 
NH (1H/ZH2) • • • • • • • 
dg/dT 4.5 4.2 4.4 4.7 4.2 4.6 4.3 
(ppm K -1 x 10 -3) 
Fig. 5. Summary of sequential nd medium-range NOE data compiled 
from the NOESY spectra of BN16 recorded at 30°C in (a) H20/2H20. 
The thickness of the bars indicates that he NOE is strong, medium and 
weak, respectively. • indicates fast-exchanging amide NHs. 
(1) 
Arg (2y 
Pro (4) 
Pro (3) 
I l e  (5 )  Arg (6) 
Pro (8) 
Tyr 
Pro (7) 
(9) 
Pro (11) 
Phe (13) ~ l~ / ~ Pr° (12) 
Arg (14) 
~ / ~  Pro (15) 
Pro (16) ~ - 
Fig. 6. A perspective view of the poly-L-proline II structure of BN16 
with the N-terminus at the top and the C-terminus at the bottom, 
deduced from molecular modeling using the NMR and NOE data 
recorded at 30°C in H20/ZH20. 
tides to associate in lipid bilayer suggests the possibility of their 
formulation in liposome drug carriers and their potential appli- 
cation in antimicrobial therapy. 
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